Von der Leyen: "On export vaccines we want reciprocity. I trust AstraZeneca, Ema will clarify"

Ursula von der Leyen (AP Photo / Francisco Seco, Pool)

• Doubts and fear spread across the American continent over the AstraZeneca vaccine

• AstraZeneca, Ema: "No evidence of direct links between vaccine and adverse events"

• Vestager to Rainews 24: "It's not a critical moment, let's think about vaccines. Alitalia? I hope a positive outcome"

Share

March 17, 2021 "If the situation does not change, we should consider whether to allow exports to countries that produce vaccines and countries that have a vaccination rate higher than ours" and "we are ready to use every tool available" to ensure compliance with the commitments made. This was stated by the president of the European Commission,

, during a press conference. In the last few weeks alone, the president said, "31 million doses have been exported (from the EU, ed) to about thirty countries" and this shows that "the EU is enforcing international cooperation, but the road that we travel must be two-way and

"he added. 

"Between the

and Europe there is a reciprocity in the export not of vaccines but in the materials and ingredients of vaccines". 

"In the last few weeks 10 million doses have been exported to the UK, which is the first recipient of doses from the European Union, despite the UK producing AstraZeneca doses" and "in our contract (with AstraZeneca, ed) two plants are mentioned. in Great Britain that should also produce doses for the EU, but we are still waiting ", therefore"

. 

"It is

why the vaccines produced in the EU go to other countries even if they produce vaccines and nothing comes back". This was stated by the president of the European Commission, Ursula von der Leyen, who recalled that 41 million doses were exported to 33 countries. "We have had this export authorization regime since February 1st. We now have transparency, we know what happens, before we were blind. This is an invitation to openness because the EU is the most open region, it was also in the last six weeks, "he added.

"In the first quarter Pfizer-BioNTech delivered 66 million doses and Moderna 10 million, respecting the contracts.

Unfortunately,

produced less,

". It should have delivered 90 million doses, it's down to 40. And the projection we have is that by the end of the month, we'll be at 30 million doses. If AstraZeneca manages to deliver what it promised, in total it will be 100 million doses in the first quarter ", he added.

" AstraZeneca has unfortunately announced that in the second quarter it will deliver 70 million doses to the European Union compared to 180 million that had contractually promised to supply ". This was stated by the president of the European Commission, Ursula von der Leyen." Unfortunately, only 70 will arrive ", he added.

Among the pharmaceutical companies with which the EU has entered into agreements" there are different levels of reliability in the supply "because"

"said Ursula von der Leyen, during a press conference. The president explains the different 'mix' of orders from member countries. verified because "not all member states bought the quantities that were due" to each country in proportion to the population and therefore some governments "bought more doses" left on me rcato from other countries.

"

. Ema will make another statement tomorrow and I am convinced that it will allow us to clarify the situation". This was stated by the president of the European Commission regarding the reports of suspected cases of side effects.